Channel 1
Tue, 02.03.2021
16:00 - 17:00
Date
Tue, 02.03.2021
Time
16:00 - 17:00
Location
Channel 1
Chairs
- Giuseppe Curigliano (Milan, Italy)
Daiichi Sankyo - Innovative Antibody Engineering: Novel technologies and preclinical and clinical outcomes
Industry satellite
Introduction (ID 347)
Lecture Time
16:00 - 16:10
Speakers
- Giuseppe Curigliano (Milan, Italy)
Session Name
Location
Channel 1, Virtual, Lugano, Switzerland
Date
Tue, 02.03.2021
Time
16:00 - 17:00
Authors
- Giuseppe Curigliano (Milan, Italy)
Daiichi Sankyo - Innovative Antibody Engineering: Novel technologies and preclinical and clinical outcomes
Industry satellite
Antibody engineering: Novel technologies, antibody drug conjugates and mechanisms of action (ID 348)
Lecture Time
16:10 - 16:30
Speakers
- Matthias Peipp (Kiel, Germany)
Session Name
Location
Channel 1, Virtual, Lugano, Switzerland
Date
Tue, 02.03.2021
Time
16:00 - 17:00
Authors
- Matthias Peipp (Kiel, Germany)
Daiichi Sankyo - Innovative Antibody Engineering: Novel technologies and preclinical and clinical outcomes
Industry satellite
Emerging preclinical and clinical data with novel antibody drug conjugates in various tumour types (ID 349)
Lecture Time
16:30 - 16:50
Speakers
- Giuseppe Curigliano (Milan, Italy)
Session Name
Location
Channel 1, Virtual, Lugano, Switzerland
Date
Tue, 02.03.2021
Time
16:00 - 17:00
Authors
- Giuseppe Curigliano (Milan, Italy)
Daiichi Sankyo - Innovative Antibody Engineering: Novel technologies and preclinical and clinical outcomes
Industry satellite
Q&A (ID 350)
Lecture Time
16:50 - 17:00
Speakers
- Giuseppe Curigliano (Milan, Italy)
Session Name
Location
Channel 1, Virtual, Lugano, Switzerland
Date
Tue, 02.03.2021
Time
16:00 - 17:00
Authors
- Giuseppe Curigliano (Milan, Italy)
- Matthias Peipp (Kiel, Germany)